#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypocalcaemia Rheumatoid arthritis Chondrosarcoma metastatic Kaposi's sarcoma Pemphigoid Extranodal marginal zone B-cell lymphoma (MALT type) Rhabdoid tumour Small intestine leiomyosarcoma Vascular malformation Acute graft versus host disease Squamous cell carcinoma of the hypopharynx Myelodysplastic syndrome with excess blasts Tourette's disorder Chronic cutaneous lupus erythematosus Granulomatosis with polyangiitis More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome – Diagnostics Hereditary hypophosphataemic rickets – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Life with Disease Leiomyosarcoma – Treatment Combined immunodeficiency – Trials in Disease Thrombotic thrombocytopenic purpura – Trials in Disease Richter’s syndrome – Basic Information Familial amyotrophic lateral sclerosis – Life with Disease Acute respiratory distress syndrome – Diagnostics Lysosomal storage disorder – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Autologous Microfat Axicabtagene Ciloleucel Mk-1942 Volixibat Cat Epithelia Burfiralimab Mexiletine Hydrochloride Stx-241 Gimeracil Autologous Chondrocytes HYALURONIDASE Alks 2680 N-Acetylhistidine RLY-2608 Azd5462 Berubicin Hydrochloride Roxadustat Apalutamide Isavuconazonium Sulfate Jab-21822 More therapies…

    Learn about Your Condition

    Monogenic diabetes Haemoptysis Colorectal cancer stage III Myeloid leukaemia Constipation Bronchopulmonary aspergillosis Neutropenia Endometrial cancer stage II Colorectal adenocarcinoma Craniosynostosis Eczema Ankylosing spondylitis Primary hypercholesterolaemia Angiopathy Transplant rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on MaaT033 to Prevent Complications in Patients with Blood Cancer Undergoing Stem Cell Transplantation

    Recruiting

    2 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Belgium France Germany The Netherlands Spain

  • Study on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma refractory
    • B-cell lymphoma
    Investigated Drugs:
    • Alemtuzumab
    • Ucart20X22
    • Aldesleukin
    France Italy Spain

  • Study on Tocilizumab and Prednisolone for Arthritis Caused by Cancer Immunotherapy in Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Eastern Cooperative Oncology Group performance status
    Investigated Drugs:
    • Prednisolone
    • Tocilizumab
    France Sweden

  • Study on the Effectiveness of Triptorelin, Goserelin Acetate, and Enzalutamide in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Triptorelin
    • Leuprorelin Acetate
    • Degarelix
    Belgium Italy

  • Study on Using Indocyanine Green for Detecting Residual Disease in Head and Neck Cancer Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Head and neck cancer
    Investigated Drugs:
    • Indocyanine Green
    Belgium France

  • Study on Tranexamic Acid to Reduce Early Relapse in Melanoma Patients Undergoing Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Tranexamic Acid
    • Placebo
    Denmark
Previous Page
1 … 579 580 581 582 583 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!